259 related articles for article (PubMed ID: 26994968)
1. Dissecting the Roles of Polycomb Repressive Complex 2 Subunits in the Control of Skin Development.
Dauber KL; Perdigoto CN; Valdes VJ; Santoriello FJ; Cohen I; Ezhkova E
J Invest Dermatol; 2016 Aug; 136(8):1647-1655. PubMed ID: 26994968
[TBL] [Abstract][Full Text] [Related]
2. Polycomb-Mediated Repression and Sonic Hedgehog Signaling Interact to Regulate Merkel Cell Specification during Skin Development.
Perdigoto CN; Dauber KL; Bar C; Tsai PC; Valdes VJ; Cohen I; Santoriello FJ; Zhao D; Zheng D; Hsu YC; Ezhkova E
PLoS Genet; 2016 Jul; 12(7):e1006151. PubMed ID: 27414999
[TBL] [Abstract][Full Text] [Related]
3. PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs.
Shan Y; Liang Z; Xing Q; Zhang T; Wang B; Tian S; Huang W; Zhang Y; Yao J; Zhu Y; Huang K; Liu Y; Wang X; Chen Q; Zhang J; Shang B; Li S; Shi X; Liao B; Zhang C; Lai K; Zhong X; Shu X; Wang J; Yao H; Chen J; Pei D; Pan G
Nat Commun; 2017 Sep; 8(1):672. PubMed ID: 28939884
[TBL] [Abstract][Full Text] [Related]
4. Deletion of Polycomb Repressive Complex 2 From Mouse Intestine Causes Loss of Stem Cells.
Koppens MA; Bounova G; Gargiulo G; Tanger E; Janssen H; Cornelissen-Steijger P; Blom M; Song JY; Wessels LF; van Lohuizen M
Gastroenterology; 2016 Oct; 151(4):684-697.e12. PubMed ID: 27342214
[TBL] [Abstract][Full Text] [Related]
5. Repressing the Keratinocyte Genome: How the Polycomb Complex Subunits Operate in Concert to Control Skin and Hair Follicle Development.
Botchkarev VA; Mardaryev AN
J Invest Dermatol; 2016 Aug; 136(8):1538-1540. PubMed ID: 27450498
[TBL] [Abstract][Full Text] [Related]
6. Polycomb subunits Ezh1 and Ezh2 regulate the Merkel cell differentiation program in skin stem cells.
Bardot ES; Valdes VJ; Zhang J; Perdigoto CN; Nicolis S; Hearn SA; Silva JM; Ezhkova E
EMBO J; 2013 Jul; 32(14):1990-2000. PubMed ID: 23673358
[TBL] [Abstract][Full Text] [Related]
7. EZH1/2 function mostly within canonical PRC2 and exhibit proliferation-dependent redundancy that shapes mutational signatures in cancer.
Wassef M; Luscan A; Aflaki S; Zielinski D; Jansen PWTC; Baymaz HI; Battistella A; Kersouani C; Servant N; Wallace MR; Romero P; Kosmider O; Just PA; Hivelin M; Jacques S; Vincent-Salomon A; Vermeulen M; Vidaud M; Pasmant E; Margueron R
Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6075-6080. PubMed ID: 30867289
[TBL] [Abstract][Full Text] [Related]
8. The H3K36me2 Methyltransferase Nsd1 Demarcates PRC2-Mediated H3K27me2 and H3K27me3 Domains in Embryonic Stem Cells.
Streubel G; Watson A; Jammula SG; Scelfo A; Fitzpatrick DJ; Oliviero G; McCole R; Conway E; Glancy E; Negri GL; Dillon E; Wynne K; Pasini D; Krogan NJ; Bracken AP; Cagney G
Mol Cell; 2018 Apr; 70(2):371-379.e5. PubMed ID: 29606589
[TBL] [Abstract][Full Text] [Related]
9. Small Molecule Approaches for Targeting the Polycomb Repressive Complex 2 (PRC2) in Cancer.
Martin MC; Zeng G; Yu J; Schiltz GE
J Med Chem; 2020 Dec; 63(24):15344-15370. PubMed ID: 33283516
[TBL] [Abstract][Full Text] [Related]
10. Polycomb repressive complex 2 component Suz12 is required for hematopoietic stem cell function and lymphopoiesis.
Lee SC; Miller S; Hyland C; Kauppi M; Lebois M; Di Rago L; Metcalf D; Kinkel SA; Josefsson EC; Blewitt ME; Majewski IJ; Alexander WS
Blood; 2015 Jul; 126(2):167-75. PubMed ID: 26036803
[TBL] [Abstract][Full Text] [Related]
11. Developmental control of polycomb subunit composition by GATA factors mediates a switch to non-canonical functions.
Xu J; Shao Z; Li D; Xie H; Kim W; Huang J; Taylor JE; Pinello L; Glass K; Jaffe JD; Yuan GC; Orkin SH
Mol Cell; 2015 Jan; 57(2):304-316. PubMed ID: 25578878
[TBL] [Abstract][Full Text] [Related]
12. Dissecting the role of H3K27 acetylation and methylation in PRC2 mediated control of cellular identity.
Lavarone E; Barbieri CM; Pasini D
Nat Commun; 2019 Apr; 10(1):1679. PubMed ID: 30976011
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-323-3p regulates the activity of polycomb repressive complex 2 (PRC2) via targeting the mRNA of embryonic ectoderm development (Eed) gene in mouse embryonic stem cells.
Zhang Y; Teng F; Luo GZ; Wang M; Tong M; Zhao X; Wang L; Wang XJ; Zhou Q
J Biol Chem; 2013 Aug; 288(33):23659-65. PubMed ID: 23821546
[TBL] [Abstract][Full Text] [Related]
14. A cytosolic Ezh1 isoform modulates a PRC2-Ezh1 epigenetic adaptive response in postmitotic cells.
Bodega B; Marasca F; Ranzani V; Cherubini A; Della Valle F; Neguembor MV; Wassef M; Zippo A; Lanzuolo C; Pagani M; Orlando V
Nat Struct Mol Biol; 2017 May; 24(5):444-452. PubMed ID: 28346433
[TBL] [Abstract][Full Text] [Related]
15. EZH1 in germ cells safeguards the function of PRC2 during spermatogenesis.
Mu W; Starmer J; Shibata Y; Yee D; Magnuson T
Dev Biol; 2017 Apr; 424(2):198-207. PubMed ID: 28254491
[TBL] [Abstract][Full Text] [Related]
16. Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.
Oliviero G; Brien GL; Waston A; Streubel G; Jerman E; Andrews D; Doyle B; Munawar N; Wynne K; Crean J; Bracken AP; Cagney G
Mol Cell Proteomics; 2016 Nov; 15(11):3450-3460. PubMed ID: 27634302
[TBL] [Abstract][Full Text] [Related]
17. HIFI-α activation underlies a functional switch in the paradoxical role of Ezh2/PRC2 in breast cancer.
Mahara S; Lee PL; Feng M; Tergaonkar V; Chng WJ; Yu Q
Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3735-44. PubMed ID: 27303043
[TBL] [Abstract][Full Text] [Related]
18. Ezh1 and Ezh2 differentially regulate PSD-95 gene transcription in developing hippocampal neurons.
Henriquez B; Bustos FJ; Aguilar R; Becerra A; Simon F; Montecino M; van Zundert B
Mol Cell Neurosci; 2013 Nov; 57():130-43. PubMed ID: 23932971
[TBL] [Abstract][Full Text] [Related]
19. Polycomb complexes redundantly maintain epidermal stem cell identity during development.
Cohen I; Bar C; Liu H; Valdes VJ; Zhao D; Galbo PM; Silva JM; Koseki H; Zheng D; Ezhkova E
Genes Dev; 2021 Mar; 35(5-6):354-366. PubMed ID: 33602871
[TBL] [Abstract][Full Text] [Related]
20. Dual inhibition of enhancer of zeste homolog 1/2 overactivates WNT signaling to deplete cancer stem cells in multiple myeloma.
Nakagawa M; Fujita S; Katsumoto T; Yamagata K; Ogawara Y; Hattori A; Kagiyama Y; Honma D; Araki K; Inoue T; Kato A; Inaki K; Wada C; Ono Y; Yamamoto M; Miura O; Nakashima Y; Kitabayashi I
Cancer Sci; 2019 Jan; 110(1):194-208. PubMed ID: 30343511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
